RECRUITING

Reducing Wound Infections Using Bioelectric Wound Dressings

Talk to us

Conditions

Surgical Site InfectionSurgery outcomesBioelectric dressing,

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to compare the outcomes of using Bioelectric wound dressing on the pre-operative wound site and post operatively and compared it outcomes to the standard of care chlorhexidine skin preparation.

Official Title

Reducing Wound Infections Using Bioelectric Wound Dressings

Quick Facts

Study Start:2024-03-04
Study Completion:2025-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06312267

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Elective diverticular, benign polyp, or colon cancer resection
  2. 2. Age 18-90 years old
  3. 3. All patients must receive some kind of bowel prep (SU- prep, pills, Go-Lytely, milk of magnesia, etc....)
  4. 4. Must be off antibiotics for more than 2 weeks before surgery
  5. 5. Surgery must be laparoscopic, hand assisted or Robotic
  6. 6. Skin will be closed in layers and subcuticular interrupted fashion
  7. 7. Just one dose of preoperative antibiotics (Invanz or equivalent if patient is allergic)
  8. 8. Patients will have a primary anastomosis, no colostomy.
  9. 9. Patient must be compliant with dressing care
  10. 10. Ability to provide informed consent
  1. 1. Active infections before surgery -example: Intra-abdominal abscess not drained or actively on antibiotics on the day of surgery, skin infections
  2. 2. Inability to take intestinal bowel preparation
  3. 3. HgbA1c \>8
  4. 4. BMI \>40
  5. 5. Immunosuppression
  6. 6. Need of steroid stress dose pre-op
  7. 7. Patient receiving active chemotherapy
  8. 8. Need of stoma (end ostomies after resection protective stoma included)
  9. 9. Need of blood transfusion during surgery
  10. 10. Use of irrigation with antibiotics or IRRISEPTR during surgery
  11. 11. Any standard contraindication to anesthesia and/or surgery
  12. 12. Pregnancy or lactating women
  13. 13. Inability to provide informed consent
  14. 14. Inability to follow instructions for dressing care
  15. 15. Sensitivity or allergy to silver or zinc

Contacts and Locations

Study Contact

Petronio Martins, MHA
CONTACT
407-303-5503
Petronio.martins@adventhealth.com
Diana Paredes, BSN
CONTACT
407-303-55-03
Diana.Paredes@adventhealth.com

Principal Investigator

Jay Redan, MD
PRINCIPAL_INVESTIGATOR
AdventHealth

Study Locations (Sites)

AdventHealth Celebration
Kissimmee, Florida, 34747
United States

Collaborators and Investigators

Sponsor: AdventHealth

  • Jay Redan, MD, PRINCIPAL_INVESTIGATOR, AdventHealth

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-04
Study Completion Date2025-03-01

Study Record Updates

Study Start Date2024-03-04
Study Completion Date2025-03-01

Terms related to this study

Keywords Provided by Researchers

  • Surgery outcomes
  • Bioelectric dressing,

Additional Relevant MeSH Terms

  • Surgical Site Infection